SynBiotic SE (SBX.DE)

EUR 4.6

(-3.97%)

Net Debt Summary of SynBiotic SE

  • SynBiotic SE's latest annual net debt in 2023 was 3.59 Million EUR , up 3.03% from previous year.
  • SynBiotic SE's latest quarterly net debt in 2023 FY was 3.59 Million EUR , up 3.03% from previous quarter.
  • SynBiotic SE reported annual net debt of 3.48 Million EUR in 2022, up 253.94% from previous year.
  • SynBiotic SE reported annual net debt of -2.26 Million EUR in 2021, up 59.74% from previous year.
  • SynBiotic SE reported quarterly net debt of - EUR for 2023 Q2, down -100.0% from previous quarter.
  • SynBiotic SE reported quarterly net debt of 3.48 Million EUR for 2022 Q4, up 1226.76% from previous quarter.

Annual Net Debt Chart of SynBiotic SE (2023 - 2018)

Historical Annual Net Debt of SynBiotic SE (2023 - 2018)

Year Net Debt Net Debt Growth
2023 3.59 Million EUR 3.03%
2022 3.48 Million EUR 253.94%
2021 -2.26 Million EUR 59.74%
2020 -5.62 Million EUR -42344.0%
2019 -13.24 Thousand EUR 0.0%
2018 - EUR 0.0%

Peer Net Debt Comparison of SynBiotic SE

Name Net Debt Net Debt Difference
MPH Health Care AG 8.5 Million EUR 57.765%
Apontis Pharma AG -20.8 Million EUR 117.265%
Dermapharm Holding SE 921.66 Million EUR 99.61%
Evotec SE 115.28 Million EUR 96.885%
MERCK Kommanditgesellschaft auf Aktien 7.95 Billion EUR 99.955%
PharmaSGP Holding SE 33.21 Million EUR 89.187%